Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

41.58
Delayed Data
As of Jun 23
 +0.41 / +1.00%
Today’s Change
37.03
Today|||52-Week Range
54.73
-8.17%
Year-to-Date
No recent news for Dr.Reddy's Laboratories Ltd.

Today’s Trading

Previous close41.17
Today’s open41.38
Day’s range41.24 - 41.61
Volume132,928
Average volume (3 months)271,774
Market cap$6.9B
Dividend yield0.72%
Data as of 4:02pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-35.32%
Earnings growth (this year)+56.08%
Earnings growth (next 5 years)+9.58%
Revenue growth (last year)-10.17%
P/E ratio0.6
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...+0.25+0.46%
ALNYAlnylam Pharmaceutic...+1.25+1.49%
UTHRUnited Therapeutics ...-0.11-0.08%
TSROTESARO Inc-3.05-2.04%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.31
Annual revenue (last year)$2.1B
Annual profit (last year)$192.8M
Net profit margin9.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts